Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab182879 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Nurulimab (anti-CTLA-4)
- Antibody type
- Recombinant
- Description
- Nurulimab (anti-CTLA-4) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4)Êhumanized monoclonal antibody.ÊNurulimab (anti-CTLA-4) can be can be used in research of melanoma.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24Êmonths.ÊUpon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Nurulimab (anti-CTLA-4) (Ab182879) - ELISA Immobilized Recombinant Human CTLA4 protein (rp176276) at 1.0 μg/mL can bind Nurulimab (anti-CTLA-4) (Ab182879) with the ECâ‚…â‚€ of 22.16 ng/mL.​
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Nurulimab (anti-CTLA-4) (Ab182879) - Flow Cytometry Flow Cytometry analysis of Jurkat cells labelling CTLA-4 (red) with Nurulimab (anti-CTLA-4) (Ab182879). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.